Pharmaceutical Technology
APRIL 23, 2024
The European Commission (EC) has granted marketing authorisation for Pfizer’s EMBLAVEO (aztreonam-avibactam), aimed at treating adults with multidrug-resistant infections where treatment options are limited.
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 23, 2024
In a significant development for healthcare quality assurance in India, the National Accreditation Board for Hospitals & Healthcare Providers (NABH) has announced the implementation plan for the 2nd Edition of NABH Accreditation Standards for Allopathic Clinics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
APRIL 23, 2024
Shares of the biotech rose about 5% after a medicine licensed from Takeda hit the main and key secondary goals of a mid-stage study focused on major depressive disorder.
Rethinking Clinical Trials
APRIL 23, 2024
In an analysis of data from the TSOS study, younger patients and patients who were publicly insured or uninsured were among several subgroups of patients who were at significant risk of missing follow-up outcome assessments. The report was published this week in Injury. Successful studies of interventions for patients with posttraumatic stress disorder (PTSD) require engaging with injured patients in long-term follow-up.
Bio Pharma Dive
APRIL 23, 2024
Giovanni Caforio, who left Bristol Myers in November after eight years as CEO, is set to succeed Novartis’ longtime board chair Joerg Reinhardt next year.
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 23, 2024
Drugs like Ozempic are very effective at helping most people who take them lose weight. Semaglutide (sold as Wegovy and Ozempic) and tirzepatide (sold as Zepbound and Mounjaro) are the most well known in the class of drugs that mimic hormones to reduce feelings of hunger.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
APRIL 23, 2024
Discover Mallinckrodt Plc's innovative patent for a filter apparatus removing liquid from gas efficiently. Learn about the unique features and benefits of this groundbreaking technology.
Bio Pharma Dive
APRIL 23, 2024
Sales of Entresto and Cosentyx grew faster in the first quarter than analysts anticipated, helping drive the quarterly beat and raise.
Pharmaceutical Technology
APRIL 23, 2024
Discover MiMedx Group Inc's patented kit for medical applications, featuring modified amniotic fluid free of salts and cells. Treat various conditions with this innovative solution.
BioPharma Reporter
APRIL 23, 2024
Celularity, a biotech company specializing in placental-derived allogeneic cell therapies, will be showcasing data at the upcoming ASGCT Annual Meeting, showcasing the potential of their off-the-shelf natural killer (NK) cells to combat age-related diseases.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
APRIL 23, 2024
Unlock the potential of nucleic acid research with Takara Holdings Inc's patented method for depleting target nucleic acids. Discover how nucleic acid guided nucleases revolutionize diagnostics and research.
Fierce Pharma
APRIL 23, 2024
Giovanni Caforio, M.D., is lining up a new gig soon after handing all his Bristol Myers Squibb leadership roles in March. | Giovanni Caforio, M.D., is lining up a new gig soon after handing all his Bristol Myers Squibb leadership roles in March. The recent Big Pharma CEO, known for steering the $74 billion acquisition of Celgene, has been proposed as the new chair at Novartis for 2025.
Pharmaceutical Technology
APRIL 23, 2024
Unlock the power of precise genetic engineering with Sangamo Therapeutics Inc's patented compositions for creating non-naturally occurring nucleases. Learn how dimers with fusion molecules can revolutionize genetic manipulation.
Antidote
APRIL 23, 2024
Equitable access to medical care is valuable for everyone, and an important part of this equation is health literacy. Health literacy encompasses not just access to medical care, but also the ability to understand and use medical guidance. This can include anything from a doctor’s suggestions, to medication dosage information, and aftercare guidance.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
APRIL 23, 2024
Discover Omeros Corp's groundbreaking patent for treating graft-versus-host disease post stem cell transplant with a MASP-2 inhibitory agent. Learn more about this innovative method now!
pharmaphorum
APRIL 23, 2024
After rejecting ImmunityBio’s Anktiva last year, the FDA has now cleared the drug as a treatment for bladder cancer, making it the biotech's first commercial-stage product
Pharmaceutical Technology
APRIL 23, 2024
Discover Insmed Inc's groundbreaking patent for lipo-glycopeptide derivatives to combat bacterial infections in the lungs, including cystic fibrosis patients. Learn about the innovative method using nebulizers, DPIs, and MDIs.
Drug Patent Watch
APRIL 23, 2024
Drug repurposing, or identifying new therapeutic uses for existing drugs, is gaining significant momentum as a promising approach to accelerate drug development and reduce costs.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
APRIL 23, 2024
Discover Bristol-Myers Squibb's innovative patent for a pharmaceutical composition targeting human CD40 activity. Learn about modified antibodies and potential treatments in this groundbreaking publication.
BioSpace
APRIL 23, 2024
This is the first round in a series of cuts that will cost 75 people their jobs this year, according to a WARN notice. Employees in other states are affected as well.
Pharmaceutical Technology
APRIL 23, 2024
Discover how Moderna's groundbreaking patent for a nucleic acid vaccine targeting varicella zoster virus could revolutionize immunization. Learn about the innovative mRNA and lipid nanoparticle technology driving this game-changing vaccine.
Fierce Pharma
APRIL 23, 2024
The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales. | The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales. But thanks to blockbuster meds across wider disease areas and other challenges, the lucrative market may soon slow down for the first time in years.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharmaceutical Technology
APRIL 23, 2024
Discover the latest patent from Hanmi Science Co Ltd for a compound binding to globulin Fc region or polypeptide. Learn about the innovative methods for preparing polypeptide conjugates and more.
Fierce Pharma
APRIL 23, 2024
As doctors and patients in the U.S. | As doctors and patients in the U.S. grapple with widening shortages of the popular diabetes therapy Mounjaro and its obesity counterpart Zepbound, the maker of the tirzepatide drugs, Eli Lilly, is forging ahead on its quest to expand capacity for its injectable medicines.
Pharmaceutical Technology
APRIL 23, 2024
Discover how Jazz Pharmaceuticals' patented CBD preparation, with over 90% CBD and a specific THC ratio, is revolutionizing disease treatment. Explore the synergistic effects of minor impurities like THC in this groundbreaking pharmaceutical composition.
pharmaphorum
APRIL 23, 2024
Unlock the power of digital health through AI and clinical advancements. Learn how these technologies are shaping the future of healthcare and how to harness their potential.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
APRIL 23, 2024
Discover Novartis AG's groundbreaking patent for the innovative KIR-CAR, a chimeric antigen receptor revolutionizing T cell therapy. Explore the unique components and potential applications of this game-changing technology.
Pharmaceutical Commerce
APRIL 23, 2024
In an interview with Pharma Commerce Associate Editor Nicholas Saraceno, Will Robinson, Commercial Director, LogiPharma, talks themes of this year's event and future plans for the show.
Pharmaceutical Technology
APRIL 23, 2024
Discover how Yuhan Corp's patent for anti-PD-L1 IgG class antibodies revolutionizes manufacturing yields. Learn about the advancements in production efficiency and potential therapeutic applications.
BioPharma Reporter
APRIL 23, 2024
At CPhI North America, Quotient Sciences is looking forward to reconnecting with its customers and giving them a preview of how we are looking to expand Translational Pharmaceutics further within the US.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
253 
Let's personalize your content